Toronto health startup in wound imaging, MolecuLight, gets CE Mark approval
The Revolutionary MolecuLight i:X Wound Imaging Device Receives CE Mark Approval | MolecuLight i:X First-ever Wound Assessment Device
Introducing the first-ever wound assessment device to provide real-time imaging of bacteria distribution at the point-of-care. The device provides instant detection of clinically important levels of bacteria. The technology is based on the detection and analysis of intrinsic fluorescence signals emitted by tissues and microbes when illuminated with specific wavelengths of light.
Join in on the conversation with Zayna Khayat when you subscribe to Toronto Health.